Latest media releases
UBS Global Life Sciences Conference Opens in New York
The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Wednesday, September 22. The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 2,000 people are expected to attend. Presenting companies include:
Agilent Technologies, Inc.
Alexion Pharmaceuticals, Inc
BioMarin Pharmaceutical Inc.
BioMed Realty Trust, Inc.
Bristol-Myers Squibb Company
Charles River Laboratories
China Shineway Pharmaceutical
Dr. Reddy's Laboratories
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
H. Lundbeck A/S
Henry Schein, Inc.
Human Genome Sciences, Inc.
Merck & Co., Inc.
Meridian Bioscience, Inc.
Mettler-Toledo International, Inc.
Myriad Genetics, Inc.
Novo Nordisk Inc.
Regeneron Pharmaceuticals, Inc.
Shanghai Fosun Pharma Group
Sino Biopharmaceutical Ltd.
Sirona Dental Systems, Inc.
Smith & Nephew
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
United Therapeutics Corporation
West Pharmaceutical Services, Inc.
*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences.
Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.
UBS draws on its 150-year heritage to serve private, institutional and corporate clients worldwide, as well as retail clients in Switzerland. We combine our wealth management, investment banking and asset management businesses with our Swiss operations to deliver superior financial solutions and manage CHF 2.2 trillion in invested assets.
UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 37% of its employees working in the Americas, 37% in Switzerland, 16% in the rest of Europe and 10% in Asia Pacific. UBS employs about 64,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).
New York: Kelly Smith at +1-212-882-5699
The products, services, information and/or materials contained within these web pages may not be available for residents of certain jurisdictions. Please consult the sales restrictions relating to the products or services in question for further information.
© UBS 1998 - 2014. All rights reserved.